Companies: 10,795·Total market cap: $144.5T
Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc

JAZZNASDAQHealthcare● Active
$238.57
$-1.49(-0.62%)
Market Cap$15.0B
P/E Ratio
52W High$243.32
52W Low$105
Overview

Jazz Pharmaceuticals plc (JAZZ) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · JAZZ · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.41jazz eps ttm · jazz earnings per shareEarnings history
PE Ratio (TTM)581.9×jazz pe ratio ttm · jazz price to earningsPE Ratio deep dive
Revenue (TTM)$4.4Bjazz revenue ttm · jazz annual revenueFull revenue history
Dividend YieldNo Dividenddoes jazz pay dividends · jazz dividend yieldDividend history
Shares Outstanding61.0Mjazz shares outstanding · jazz floatShares outstanding history
Next EarningsAug 4, 2026Est.jazz earnings date · jazz next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$4.27B▲ +4.88% YoY
202320242025
jazz pharmaceuticals plc revenue · jazz revenue 2025
FY 2025Net Income-$356.1M▼ 163.58% YoY
202320242025
jazz pharmaceuticals plc net income · jazz profit 2025
FY 2025EPS$-5.84▼ 164.46% YoY
202320242025
jazz eps · jazz pharmaceuticals plc earnings per share 2025
TTM:Revenue: $4.44BNet Income: $29.5MEPS: $0.41View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy48 analystsis jazz a buy · jazz analyst rating
Strong Buy
0
Buy
43
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$229.00Low
$238.57Current
$257.63Avg Target7.99% upside
$307.00High
jazz price target · jazz 12 month forecast

Total: 48 · Buy rate: 89.6%

The JAZZ analyst consensus is Buy, based on ratings from 48 Wall Street analysts over the past 3 months. The average 12-month price target is $257.63, representing +7.99% upside from the current price of $238.57.

Stock Performance

Full History
1D-0.62%
1W+5.51%
1M+5.66%
3M+31.08%
YTD+40.34%
1Y+113.26%
5Y+33.32%

About Jazz Pharmaceuticals plc

CEORenee D. Gala
IPO DateJun 1, 2007
Employees2,800
CountryUS

Jazz Pharmaceuticals plc a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationall…

what is jazz pharmaceuticals plc · jazz stock overview · jazz pharmaceuticals plc company profile · who is jazz pharmaceuticals plc ceo · jazz NASDAQ · jazz pharmaceuticals plc headquarters · jazz pharmaceuticals plc business segments

About Stock Overview & Key Data

Jazz Pharmaceuticals plc (JAZZ) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 1, 2007. As of the latest trading session, JAZZ stock price is $238.57, with a market capitalization of $15.0B. The stock has returned +113.26% over the past 12 months and +40.34% year-to-date.

According to 48 Wall Street analysts, the consensus rating for Jazz Pharmaceuticals plc stock is Buy, with an average 12-month price target of $257.63. In fiscal year 2025, Jazz Pharmaceuticals plc reported revenue of $4.3B and net income of -$356.1M. For detailed data — including Jazz Pharmaceuticals plc revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Jazz Pharmaceuticals plc (JAZZ) stock price is $238.57. The stock is traded on NASDAQ under the ticker symbol JAZZ. The 52-week range is $105.00 – $243.32.

JAZZ stock priceJAZZ quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice